CAPRICOR THERAPEUTICS, INC. Research and Development in Process
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Research and Development in Process of $1.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2016-03-30
- CAPRICOR THERAPEUTICS, INC. research and development in process for the quarter ending 2015-12-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. research and development in process for the quarter ending 2015-09-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. research and development in process for the quarter ending 2015-06-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. research and development in process for the quarter ending 2015-03-31 was $1.50M, a 0.00% change year-over-year.
- CAPRICOR THERAPEUTICS, INC. research and development in process for fiscal 2015 was $1.50M, a 0.00% change from fiscal 2014.
- CAPRICOR THERAPEUTICS, INC. research and development in process for fiscal 2014 was $1.50M, a 0.00% change from fiscal 2013.
- CAPRICOR THERAPEUTICS, INC. research and development in process for fiscal 2013 was $1.50M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $1.50M 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $1.50M 10-Q · filed 2015-11-13 | $1.50M derived: sum of 4 quarters · filed 2015-11-13 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $1.50M 10-Q · filed 2015-08-14 | $1.50M derived: sum of 3 quarters · filed 2015-08-14 | $1.50M derived: sum of 4 quarters · filed 2015-08-14 |
| 2015-03-31 | $1.50M 10-Q · filed 2015-05-13 | $1.50M derived: sum of 2 quarters · filed 2015-05-13 | $1.50M derived: sum of 3 quarters · filed 2015-05-13 | $1.50M derived: sum of 4 quarters · filed 2015-05-13 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $0.00 derived: sum of 3 quarters · filed 2015-03-16 | $1.50M 10-K · filed 2015-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $1.50M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.50M 10-Q · filed 2014-08-14 | ||
| 2014-03-31 | $1.50M 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $1.50M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |